title: Pharmacotherapy of pediatric and adolescent HIV infection.
abstract: Significant advances have been made in the treatment of human immunodeficiency virus (HIV) infection over the past two decades. Improved therapy has prolonged survival and improved clinical outcome for HIV-infected children and adults. Sixteen antiretroviral (ART) medications have been approved for use in pediatric HIV infection. The Department of Health and Human Services (DHHS) has issued "Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection", which provide detailed information on currently recommended antiretroviral therapies (ART). However, consultation with an HIV specialist is recommended as the current therapy of pediatric HIV therapy is complex and rapidly evolving.
authors.affiliation: Division of Allergy/Immunology, Department of Pediatrics, North Shore - Long Island Jewish Health System, Great Neck, NY, USA;
authors.forename: Susan J
authors.initials: SJ
authors.lastname: Schuval
references.citation: J Infect Dis. 2008 Dec 1;198(11):1599-608
references.pmid: 19000014
references.citation: AIDS. 2009 Mar 13;23(5):639-41
references.pmid: 19242316
references.citation: J Pediatr. 1998 Oct;133(4):500-8
references.pmid: 9787687
references.citation: J Antimicrob Chemother. 2008 Jun;61(6):1336-9
references.pmid: 18343800
references.citation: AIDS. 2006 Nov 28;20(18):2315-9
references.pmid: 17117017
references.citation: Pediatrics. 2006 Sep;118(3):e711-8
references.pmid: 16923923
references.citation: J Acquir Immune Defic Syndr. 2009 May 1;51(1):54-9
references.pmid: 19282779
references.citation: Eur J Med Res. 2005 Dec 7;10(12):503-8
references.pmid: 16356864
references.citation: Lancet. 1996 Sep 28;348(9031):863-8
references.pmid: 8826814
references.citation: AIDS. 2003 Jul 25;17(11):1639-47
references.pmid: 12853746
references.citation: Ann Pharmacother. 2006 Apr;40(4):704-9
references.pmid: 16551767
references.citation: AIDS. 2006 Jun 12;20(9):1289-94
references.pmid: 16816558
references.citation: Clin Infect Dis. 2008 Jun 1;46(11):1751-60
references.pmid: 18426371
references.citation: Antivir Ther. 2004 Apr;9(2):297-9
references.pmid: 15134193
references.citation: N Engl J Med. 1997 May 8;336(19):1343-9
references.pmid: 9134874
references.citation: N Engl J Med. 2008 Feb 7;358(6):568-79
references.pmid: 18256392
references.citation: Clin Infect Dis. 2009 Apr 1;48(7):931-9
references.pmid: 19231980
references.citation: AIDS Res Hum Retroviruses. 2000 Mar 20;16(5):415-21
references.pmid: 10772527
references.citation: AIDS. 2003 Sep 26;17(14):2045-52
references.pmid: 14502007
references.citation: BMJ. 2006 Jun 24;332(7556):1489
references.pmid: 16793811
references.citation: N Engl J Med. 1997 Jun 12;336(24):1704-12
references.pmid: 9182213
references.citation: Ther Clin Risk Manag. 2008 Apr;4(2):473-85
references.pmid: 18728830
references.citation: Pediatrics. 1999 May;103(5):e62
references.pmid: 10224206
references.citation: AIDS. 2007 May 11;21(8):947-55
references.pmid: 17457088
references.citation: Ann Pharmacother. 2004 Nov;38(11):1924-34
references.pmid: 15479772
references.citation: N Engl J Med. 2003 May 29;348(22):2175-85
references.pmid: 12637625
references.citation: Eur J Pediatr. 2009 Apr;168(4):387-92
references.pmid: 19152000
references.citation: Pediatr Infect Dis J. 2009 Mar;28(3):204-9
references.pmid: 19209091
references.citation: J Infect Dis. 2001 Apr 1;183(7):1116-20
references.pmid: 11237839
references.citation: Pediatr Infect Dis J. 2003 Mar;22(3):216-24
references.pmid: 12634581
references.citation: Pharmacotherapy. 2009 Mar;29(3):281-94
references.pmid: 19249947
references.citation: Arch Dis Child. 2009 Jan;94(1):70-4
references.pmid: 18838416
references.citation: Pediatrics. 2001 Jan;107(1):E4
references.pmid: 11134468
references.citation: Pediatrics. 2007 Aug;120(2):e416-23
references.pmid: 17646352
references.citation: N Engl J Med. 2008 Oct 2;359(14):1429-41
references.pmid: 18832244
references.citation: Antimicrob Agents Chemother. 2009 Feb;53(2):631-8
references.pmid: 19047650
references.citation: N Engl J Med. 1999 Dec 16;341(25):1874-81
references.pmid: 10601506
references.citation: J Antimicrob Chemother. 2008 Jan;61(1):183-90
references.pmid: 18025025
references.citation: Pediatr Infect Dis J. 2008 May;27(5):431-7
references.pmid: 18382386
references.citation: N Engl J Med. 2003 May 29;348(22):2228-38
references.pmid: 12773651
references.citation: Pediatr Infect Dis J. 2009 Feb;28(2):159-61
references.pmid: 19106779
references.citation: Pediatrics. 2008 Apr;121(4):e827-35
references.pmid: 18332076
references.citation: N Engl J Med. 2001 Nov 22;345(21):1522-8
references.pmid: 11794218
references.citation: Lancet. 2002 Mar 2;359(9308):733-40
references.pmid: 11888583
references.citation: N Engl J Med. 2004 Jun 10;350(24):2471-80
references.pmid: 15190139
references.citation: Lancet Infect Dis. 2002 Feb;2(2):93-102
references.pmid: 11901656
references.citation: BMC Infect Dis. 2006 Jul 11;6:107
references.pmid: 16834769
references.citation: AIDS. 2009 Mar 13;23(5):597-604
references.pmid: 19194272
references.citation: Pediatrics. 2006 Mar;117(3):e528-36
references.pmid: 16481448